Isofol Medical's IPO

Isofol Medical raised a round of funding on April 04, 2017. Investors include Public.

Isofol Medical is a clinical stage pharmaceutical company headquartered in Gothenburg, Sweden. Its lead candidate, Modufolin, is a novel folate-based therapy developed to increase the efficacy and red…

Articles about Isofol Medical's IPO: